Pancreatic cancer could be diagnosed up to three years earlier—new study

Pancreatic cancer could be diagnosed up to three years earlier—new study
Credit: AI-generated image (disclaimer)

Every year, more than 10,000 people in the UK are diagnosed with pancreatic cancer. Unfortunately, for most of those people, the disease is diagnosed too late to be cured. Less than 10% of people live five years following a diagnosis.

Pancreatic is a silent disease. For many people, it has no symptoms until it is fairly advanced. Weight loss and increased are known signs, but it has been unknown—until now—when these changes occur and to what extent. If we can better understand how and when these changes happen before pancreatic cancer diagnosis, we can use this knowledge to diagnose the disease earlier and potentially, in the future, save the lives of some of the people affected by this deadly disease.

In the largest study of its kind, published in PLOS ONE, researchers at the University of Surrey, together with researchers at the University of Oxford, investigated known signs of pancreatic cancer—weight loss, and diabetes—and looked at when they develop in relation to cancer. To undertake this research, we used a of more than 10 million people in England. The large size of the dataset was important to ensure that our findings represent the whole population. We extracted the information on pancreatic cancer diagnosis and the three attributes of interest and investigated how they change for people over time.

We compared the (for weight loss) and HbA1c (for ) of nearly 9,000 people diagnosed with pancreatic cancer with those of a group of nearly 35,000 people who did not have the disease. We found that dramatic weight loss in people with pancreatic cancer started as early as two years before they received a diagnosis.

At the time of diagnosis, the average BMI of people with pancreatic cancer was nearly three units lower than people who did not have cancer. Raised glucose levels were detected even earlier—from three years before the diagnosis.

Our analysis revealed that weight loss in people with diabetes was associated with a higher risk of developing pancreatic cancer than in people without diabetes. And increasing glucose levels in people without diabetes was associated with a higher risk of pancreatic cancer than in people with diabetes.

The results suggest that unexplained weight loss, mainly in people with diabetes (but not exclusively) should be treated with suspicion. Also, increasing glucose levels, especially in people without , should be considered a potential red flag for pancreatic cancer.

These changes are important candidates for health checks that, if performed regularly, could help doctors identify people who may have undiagnosed pancreatic cancer. These people could be then referred to a hospital specialist for an abdominal scan to check for cancer.

The benefit of receiving an is that it reduces the chance of the cancer spreading and helps ensure patients are fit enough to withstand treatment.

Where we go from here

In our study, we looked at average rates. It would be important in the future to delve deeper into data and investigate individuals or groups of people who are more likely to experience and increased . This approach could then focus on helping those people.

We are also looking to build this information into a more complex tool (an algorithm) that doctors could use. Using weight and glucose changes together, and potentially incorporating other key symptoms of (dark urine, light stool, yellow skin), is more powerful than looking at each of these measures separately. Such a tool could be a powerful way to improve early diagnosis and save lives.

More information: Agnieszka Lemanska et al, BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database, PLOS ONE (2022). DOI: 10.1371/journal.pone.0275369

Journal information: PLoS ONE
Provided by The Conversation

This article is republished from The Conversation under a Creative Commons license. Read the original article.The Conversation

Citation: Pancreatic cancer could be diagnosed up to three years earlier—new study (2022, November 1) retrieved 15 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study reveals alarming failures in the detection of pancreatic cancer


Feedback to editors